These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 7878405)
1. [Hypertension and vascular diseases: molecular and cellular mechanisms]. Lüscher TF Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405 [TBL] [Abstract][Full Text] [Related]
2. [Molecular and cellular mechanisms of arteriosclerosis and restenosis: possibilities of gene therapy]. Lüscher TF; Oemar BS; Yang Z; Noll G Z Kardiol; 1996 Jul; 85(7):495-508. PubMed ID: 8928548 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors]. Tschudi MR; Noll G; Lüscher TP Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890 [TBL] [Abstract][Full Text] [Related]
5. [Role of endothelial nitric oxide in the regulation of the vasomotor system]. Michel JB Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914 [TBL] [Abstract][Full Text] [Related]
6. [Molecular medicine and gene therapy as exemplified with arteriosclerosis and restenosis]. Lüscher TF; Oemar BS; Yang Z; Noll G Schweiz Med Wochenschr; 1995 Nov; 125(44):2107-21. PubMed ID: 7502010 [TBL] [Abstract][Full Text] [Related]
8. Endothelium dysfunction in the coronary circulation. Lüscher TF; Noll G J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060 [TBL] [Abstract][Full Text] [Related]
9. Endothelium in the control of vascular tone and growth: role of local mediators and mechanical forces. Lüscher TF Blood Press Suppl; 1994; 1():18-22. PubMed ID: 8205293 [TBL] [Abstract][Full Text] [Related]
10. Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion. Lüscher TF; Yang ZH; Diederich D; Bühler FR J Cardiovasc Pharmacol; 1989; 14 Suppl 6():S63-9. PubMed ID: 2478827 [TBL] [Abstract][Full Text] [Related]
12. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals. Miller AL Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191 [TBL] [Abstract][Full Text] [Related]
13. Vascular smooth muscle and endothelial functions in aging. Yildiz O Ann N Y Acad Sci; 2007 Apr; 1100():353-60. PubMed ID: 17460198 [TBL] [Abstract][Full Text] [Related]
14. [New information on the pathophysiology of atherosclerosis]. Reiner Z; Tedeschi-Reiner E Lijec Vjesn; 2001; 123(1-2):26-31. PubMed ID: 11379194 [TBL] [Abstract][Full Text] [Related]
16. Vascular gap junctions and implications for hypertension. Rummery NM; Hill CE Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):659-67. PubMed ID: 15554905 [TBL] [Abstract][Full Text] [Related]
17. [Endothelial dysfunction and coronary heart disease. Interaction of endothelium and thrombocytes]. Vanhoutte PM Schweiz Rundsch Med Prax; 1993 Oct; 82(42):1161-6. PubMed ID: 8248687 [TBL] [Abstract][Full Text] [Related]
18. Hypertension and atherosclerosis. Cause and effect, or two effects with one unknown cause? Bondjers G; Glukhova M; Hansson GK; Postnov YV; Reidy MA; Schwartz SM Circulation; 1991 Dec; 84(6 Suppl):VI2-16. PubMed ID: 1959216 [TBL] [Abstract][Full Text] [Related]
19. [Thrombocyte inhibitors in cardiovascular therapy]. Lüscher TF; Pfisterer M Schweiz Rundsch Med Prax; 1990 Sep; 79(39):1132-41. PubMed ID: 2218249 [TBL] [Abstract][Full Text] [Related]
20. Influence of hypertension and of antihypertensive drugs on the arterial wall. Chobanian AV Clin Physiol Biochem; 1988; 6(3-4):201-9. PubMed ID: 3060297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]